author-photo

Giovanni Martinelli

European Institute of Oncology

135

Papers

9305

Citations

Citation Trend

Filter By

Papers (135) Sort By

Journal Conference Others

SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model.

2020 Blood Advances
Show All
- Source
- Cite
- Save
Citations (16)
Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma

2017 Haematologica
Show All
- Source
- Cite
- Save
Citations (30)
High dose 90Yttrium ibritumomab tiuxetan with PBSC support in refractory-resistant NHL patients: Preliminary results of a phase I/II study

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of International Extranodal Lymphoma Study Group (IELSG)

2016 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (32)
Core needle biopsy as a front line diagnostic approach for lymphoma patients.

2015 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Chlorambucil-rituximab as first-line therapy in patients affected by follicular non-Hodgkin's lymphoma: a retrospective single-centre study.

2015 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (8)
A retrospective international study on primary extranodal marginal zone lymphomas of the lung (BALT lymphoma) on behalf of the international lymphoma study group (IELSG)

2015
Show All
- Source
- Cite
- Save
Citations (5)
Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (117)
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group.

2014 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (32)
An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL) and Follicular Lymphoma (FL)

2014 Blood
Show All
- Source
- Cite
- Save
Citations (16)